Simultaneous Determination and validation of Ziprasidone Hydrochloride in Dosage form by Densitometric

Please use this identifier to cite or link to this item: http://dspace.mediu.edu.my:8181/xmlui/handle/123456789/5705

Full metadata record

DC Field	Value	Language
dc.creator	M.C. Sharma, S. Sharma , A.D. Sharma	-
dc.date	2011	-
dc.date.accessioned	2013-05-30T13:18:45Z	-
dc.date.available	2013-05-30T13:18:45Z	-
dc.date.issued	2013-05-30	-
dc.identifier	http://ditonline.info/article/view/8120/4146	-
dc.identifier	http://www.doaj.org/doaj?func=openurl&genre=article&issn=09757619&date=2011&volume=3&issue=6&spage=102	-
dc.identifier.uri	http://koha.mediu.edu.my:8181/jspui/handle/123456789/5705	-
dc.description	A simple, rapid and accurate High-performance thin-layer chromatography method has been established and validated for the simultaneous determination of Ziprasidone Hydrochloride in tablets. The method is based on HPTLC separation of the drugs followed by densitometric measurements of their spots at 277 nm. The separation was carried out on Merck TLC aluminium sheets of silica gel 60F-254 using mobile phase consisting of benzene: ethyl acetate: methanol: glacial acetic acid (4.0: 1.0:0.5:0.1 v/v/v/v). Calibration curves were linear in range of 1.625- 14.625 μg/spot and 0.1 - 0.9 μg/spot for Ziprasidone Hydrochloride.	-
dc.publisher	Association of Pharmaceutical Innovators	-
dc.source	Drug Invention Today	-
dc.subject	Ziprasidone hydrochloride	-
dc.subject	HPTLC	-
dc.subject	Validation	-
dc.title	Simultaneous Determination and validation of Ziprasidone Hydrochloride in Dosage form by Densitometric	-
Appears in Collections:	Health Sciences

Files in This Item:

There are no files associated with this item.

DSpace JSPUI